Clinical Trial: Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916884) titled 'Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine' on April 01.

Brief Summary: Phase IIIb , longitudinal, multicenter, randomized, double-blind, to evaluate efficacy and safety of the fixed-dose combination of Desloratadine 5 mg / Betamethasone 0.25 mg versus Desloratadine 5 mg monotherapy as treatment for symptoms associated with allergic rhinitis.

Study Start Date: Nov. 11, 2024

Study Type: INTERVENTIONAL

Condition: Allergic Rhinitis

Intervention: DRUG: Desloratadine / Betamethasone in fixed dose

1 tablet, once a day of 5 mg / 0.25 mg

DRUG: Deslo...